We are live on
!
Find out more
BA
BlackRock Advisors Portfolio holdings
AUM
$98.8B
1-Year Est. Return
15.8%
This Fund
S&P 500
This Quarter
Est. Return
-7.26%
1 Year Est. Return
+15.8%
3 Year Est. Return
+32.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$93.3B
AUM Growth
-$2.89B
(-3%)
Cap. Flow
+$5.74B
Cap. Flow
% of AUM
6.15%
Top 10 Holdings %
Top 10 Hldgs %
15.28%
Holding
3,878
New
163
Increased
1,568
Reduced
1,679
Closed
111
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$423M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$367M |
| 3 |
ExxonMobil
XOM
|
+$337M |
| 4 |
Johnson & Johnson
JNJ
|
+$257M |
| 5 |
Biogen
BIIB
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$195M |
| 2 |
AbbVie
ABBV
|
+$188M |
| 3 |
JPMorgan Chase
JPM
|
+$183M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$176M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$174M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.49% |
| 2 | Financials | 16.75% |
| 3 | Technology | 9.99% |
| 4 | Industrials | 8.32% |
| 5 | Energy | 7.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBF
2226
DELISTED
Capital Bank Financial Corp. Class A Common Stock
CBF
| $465K | ﹤0.01% |
15,398
-319
| -2% | -$9.56K |
|
|
WAIR
2227
DELISTED
WESCO Aircraft Holdings Inc.
WAIR
| $464K | ﹤0.01% |
38,055
-1,110
| -3% | -$15.6K |
|
2228
Manitowoc
MTW
$495M
| $463K | ﹤0.01% |
34,068
-163,573
| -83% | -$2.53M |
|
2229
Quantum Corp
QMCO
$439M
| $462K | ﹤0.01% |
4,138
-12,130
| -75% | -$2.24M |
|
|
ATRI
2230
DELISTED
Atrion Corp
ATRI
| $462K | ﹤0.01% |
1,231
+264
| +27% | +$102K |
|
|
VIVO
2231
DELISTED
Meridian Bioscience Inc
VIVO
| $461K | ﹤0.01% |
26,985
-840
| -3% | -$15.4K |
|
2232
Adtran
ADTN
$677M
| $460K | ﹤0.01% |
31,509
-3,644
| -10% | -$57.5K |
|
|
BRKL
2233
DELISTED
Brookline Bancorp
BRKL
| $460K | ﹤0.01% |
45,379
-792,553
| -95% | -$8.62M |
|
|
WCC
2234
WESCO International
WCC
$15.5B
| $460K | ﹤0.01% |
9,897
+3,308
| +50% | +$191K |
|
|
INVN
2235
DELISTED
Invensense Inc
INVN
| $460K | ﹤0.01% |
49,538
-780
| -2% | -$8.76K |
|
2236
COPT Defense Properties
CDP
$4.35B
| $459K | ﹤0.01% |
21,825
+8,418
| +63% | +$190K |
|
2237
Erie Indemnity
ERIE
$12.8B
| $459K | ﹤0.01% |
5,529
+1,809
| +49% | +$151K |
|
2238
Iovance Biotherapeutics
IOVA
$2.03B
| $459K | ﹤0.01% |
79,664
-68,572
| -46% | -$534K |
|
2239
Heron Therapeutics
HRTX
$93.5M
| $458K | ﹤0.01% |
18,762
+2,550
| +16% | +$85K |
|
2240
Enviri
NVRI
$637M
| $458K | ﹤0.01% |
50,499
-1,729
| -3% | -$21.8K |
|
|
ONIT
2241
Onity Group
ONIT
$339M
| $458K | ﹤0.01% |
4,551
-138
| -3% | -$17.5K |
|
2242
United Fire Group
UFCS
$1.35B
| $457K | ﹤0.01% |
13,051
-512
| -4% | -$17.7K |
|
2243
Westlake Corp
WLK
$9.14B
| $457K | ﹤0.01% |
8,809
+2,776
| +46% | +$162K |
|
2244
Timken Company
TKR
$9.27B
| $456K | ﹤0.01% |
16,591
-116,880
| -88% | -$3.73M |
|
|
IRC
2245
DELISTED
INLAND REAL ESTATE CORP
IRC
| $456K | ﹤0.01% |
56,276
-1,639
| -3% | -$14.9K |
|
2246
Walker & Dunlop
WD
$1.76B
| $454K | ﹤0.01% |
17,426
-248
| -1% | -$6.2K |
|
2247
Employers Holdings
EIG
$908M
| $453K | ﹤0.01% |
20,312
-680
| -3% | -$15.7K |
|
|
ZAYO
2248
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $453K | ﹤0.01% |
17,882
+11,670
| +188% | +$314K |
|
2249
Qualys
QLYS
$4.73B
| $451K | ﹤0.01% |
15,858
+250
| +2% | +$8.39K |
|
|
LMNX
2250
DELISTED
Luminex Corp
LMNX
| $450K | ﹤0.01% |
26,593
-1,062
| -4% | -$19.2K |
|
Similar funds
BIM
BJ
IC
EAM
MFS
CIM
KAM
PFM
BlackRock Advisors's Q3 2015 Portfolio in Review
As of Q3 2015, BlackRock Advisors held 3,878 positions worth $93.3B, down 3% from $96.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BlackRock Advisors deployed $5.74B of net new capital in Q3 2015, opening 163 new positions and adding to 1,568 existing holdings. Its largest new stake was Allergan plc: 186,940 shares worth $176M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 20% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $195M trimmed.
- BlackRock Advisors's largest Q3 2015 buy was Allergan plc: 186,940 shares worth $176M.
- BlackRock Advisors added most to Apple in Q3 2015, an estimated $423M increase.
- BlackRock Advisors's biggest Q3 2015 reduction was Vertex Pharmaceuticals, cutting an estimated $195M.
- BlackRock Advisors fully exited RECEPTOS INC COM STK (DE) in Q3 2015, selling an estimated $108M.
- BlackRock Advisors's ten largest holdings make up 15% of its $93.3B portfolio in Q3 2015.
- BlackRock Advisors opened 163 new positions and closed 111 in Q3 2015.
- BlackRock Advisors's portfolio value fell 3% quarter-over-quarter to $93.3B.
Based on BlackRock Advisors's 13F filing for Q3 2015, filed 13 Nov 2015.